Indian Pharma Companies
-
{
- All
- News
- Videos
-
India's Pharma Opportunity: Expanding Global Reach In A Changing Healthcare Landscape
India's pharmaceutical industry is now at a critical juncture in its evolution.
-
"Someone Duplicated Cough Syrup": Indian Pharma After WHO Alert
After the WHO issued a product alert over India-made cough syrup in Marshal Islands and Micronesia, Managing Director, QP Pharma Chem Limited, Sudhir Pathak said that someone had duplicated the syrup to defame the Government of India.
-
China's Plan To Import Indian Medicines Receives Cold Response From Pharma Firms
China's much-publicised announcement to slash tariffs on 28 medicines, including cancer drugs from India, has failed to create any buzz among the Indian pharmaceutical firms as exports to China are possible only after lengthy field trials and approvals, which could take years, an official at an Indian firm has said.
-
After H-1B, Strong Rupee The New Worry For Indian Tech Companies
For information technology and drug companies already contending with an American clampdown on working visas and a wave of unfavorable inspections by the U.S. Food and Drug Administration, rupee strength is another headache.
-
India's Pharma Opportunity: Expanding Global Reach In A Changing Healthcare Landscape
India's pharmaceutical industry is now at a critical juncture in its evolution.
-
"Someone Duplicated Cough Syrup": Indian Pharma After WHO Alert
After the WHO issued a product alert over India-made cough syrup in Marshal Islands and Micronesia, Managing Director, QP Pharma Chem Limited, Sudhir Pathak said that someone had duplicated the syrup to defame the Government of India.
-
China's Plan To Import Indian Medicines Receives Cold Response From Pharma Firms
China's much-publicised announcement to slash tariffs on 28 medicines, including cancer drugs from India, has failed to create any buzz among the Indian pharmaceutical firms as exports to China are possible only after lengthy field trials and approvals, which could take years, an official at an Indian firm has said.
-
After H-1B, Strong Rupee The New Worry For Indian Tech Companies
For information technology and drug companies already contending with an American clampdown on working visas and a wave of unfavorable inspections by the U.S. Food and Drug Administration, rupee strength is another headache.
